Richard S. Levy - 14 May 2025 Form 4/A - Amendment Insider Report for Protara Therapeutics, Inc. (TARA)

Role: Director
Signature: /s/ Mary Grendell, Attorney-in-fact
Issuer symbol: TARA
Transactions as of: 14 May 2025
Net transactions value: +$63,800
Form type: 4/A - Amendment
Filing time: 19 May 2025, 16:10:10 UTC
Date Of Original Report: 16 May 2025
Previous filing: 11 Apr 2025
Next filing: 05 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Levy Richard S	Director	C/O PROTARA THERAPEUTICS, INC., 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK	/s/ Mary Grendell, Attorney-in-fact	19 May 2025	0001454983

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TARA	Common Stock	Purchase	$63,800	+20,000	+65%	$3.19	51,000	14 May 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.15 to $3.22, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.15 to $3.22, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Remarks:

This amendment is to revise the footnote above to reflect that the transactions that are the subject of this Form 4 were purchases, not sales, of shares of TARA.